Clinical Trial Update: Clinical Efficacy of Tranexamic Acid and ε-Aminocaproic Acid in Reducing Blood Loss Following Total Knee Replacement [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated whether tranexamic acid and epsilon-aminocaproic acid reduce blood loss after total knee replacement in osteoarthritis patients; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Epsilon-aminocaproic acid (epsilon-aminocaproic acid)
• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Miller Orthopedic Specialists | Conditions: Osteoarthritis | Phase 4 | Status: COMPLETED